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Material and Methods:
In five patients with brain tumors, CT and contrast-enhanced T1-weighted fast-spin-echo sequences (1.5T GE MRI, TR = 756ms, TE= 7.152ms, reformatted resolution of 1.01x1.01x3mm3), were registered. MRIs were preprocessed by removing background and making tissues contrast more consistent. 2D patches, defined as MRI squares of 5x5voxels, in each voxel position, were pre-computed for all MRIs and labeled with HU values of registered CTs to form a database of patches with corresponding target HU values. The most similar patches (k= 8) to each given patch in test MRI, were locally searched (ROI= 15x15x15 mm3) from the database and their corresponding CT intensities were fused to predict its pCT value. Efficient local search region delimitation was possible by affine mapping between test and database MRI images. "Structural similarity measure" and "sum of squared difference" between database and test patches were used respectively for CT voxels positions selections and intensities weighting, when averaging them to estimate pCT value. Geometric and dosimetric assessments of the pCT were performed for all patients using leave one out crossvalidation. Voxel-wise Mean Absolute Error (MAE) and Mean Errors (ME) were computed to assess pCT and DRR intensities. Bone and air cavities geometry were quantified by dice indices. MAE Water Equivalent Path Length (MAE_WEPL) was computed for multiple 3D rays from the center of the head toward the upper hemisphere to evaluate the radiological path length. VMAT planning was done on generated pCT for all patients in Varian Eclipse (AAA algorithm) and RaySearch RayStation (Collapsed Cone algorithm) TPS for PTV, defined in a heterogeneous region including bone, air and soft-tissues. PTV, OARs and VMAT plans were copied to CT and dose computed for validation. DVH and other dosimetric parameters were compared between pCT and CT plans. Figure 1 gives the visual assessment of the generated pCT and DRR. Mean MAE, ME and MAE_WEPL values for pCT evaluation were 138.5 (σ= 15.3), 29 (σ= 16.1), and 32.5(σ= 3.36), respectively. DICE index for bone and air cavities was 0.76 (σ= 0.02) and 0.63 (σ= 0.1), respectively. DRR average errors were: MAE=169.3 (σ=11.2) and ME =125.5 (σ=33.8). Table 1 gives average dosimetric errors between pCT and CT for PTV and OARs, computed on Eclipse and RayStation TPS. The absolute dosimertic agreement between pCT and CT is within 1% for PTV and within 2% for OARs except for optic nerves in Eclipse (P-value = 0.57 > 0.05).
Results:

Conclusion:
A promising study on the generation and validation of CT-substitute from standard clinical T1 MRI is presented. Further work will be done to assess and improve the method on more patients and different clinical sites. The study aims at evaluating the dosimetric effect of the metal artifact reduction (MAR) function for three different types of dose calculation algorithms in H&N radiotherapy.
EP-1835 Dosimetric effect of metal artifact reduction function by three calculation algorithms for H&N J. Park
Material and Methods:
A virtual H&N patient (vH&N) was designed based on a round-shaped dosimetric phantom (cheese phantom). Two types of metal (tungsten 4.59g/cm3 and Cerrobend alloy 9.4g/cm3: Ø3 cm) were inserted into the vH&N to simulate an H&N patient with dental prosthesis. We obtained two types of CT image sets with MAR-on and MARoff conditions and imported a contour set for the PTV, parotid, and spinal cord, which from a Nasopharynx case. An IMRT with five step & shoot beams was created for the MARoff CT image set using the Monte Carlo dose calculation algorithm (MC, iPlan, BrainLAB) by following RTOG1197 guidelines. Two different plans were calculated by applying pencil beam (PB) and collapsed cone convolution (CCC) dose calculation algorithms with the same beam parameters and MLC shape. The same procedure was applied to the MAR-on CT image set. A total of six plans with the same beam parameters were generated. We calculated dose at five points of interest and compared with the doses measured at the same points. The 2D axial dose distribution was evaluated through film dosimetry by applying Gamma analysis with 3 mm and 3% criteria for all plans.
Results:
The differences between the measured and calculated doses at the five points of interest for the MAR-on CT image set were significantly low compared to those for the MAR-off CT image set in all dose calculation algorithms (-1.6±1.8 vs -5.8±9%). The dose differences were the lowest in MC followed by CCC and PB. The most significant dose difference between MAR-on and MAR-off was observed in PB followed by MC and CCC. In the gamma analysis, the mean pass rate was significantly high in MAR-on compared to that in MAR-off (89.8±8 vs 61.6±16%). The pass rate was the highest in MC followed by CCC and PB. The most significant pass rate difference between MAR-on and MAR-off was observed in CCC (91.8 vs 45.4%) followed by MC (96.7 vs 62.3%) and PB (81.1 vs 77.1%).
Conclusion:
The dose calculation results with the MAR-on CT image set and MC showed better fit to measured data compared to the MAR-off CT image set with the other dose calculation algorithms. PB was more sensitive to metal artifacts for dose calculation of H&N followed by MC and CCC. MAR-on could thus provide a more realistic dose distribution for H&N with metal prosthesis. Purpose or Objective: To assess dual-energy CT (DECT) and Metal Artefact Reduction algorithm (MAR) for radiotherapy planning. In particular, conversion of HU to electron density is evaluated in terms of monochromatic energy and the use of MAR in the presence of metal materials.
EP-1836 HU to electron density conversion with virtual monochromatic images generated by dual-energy CT V. González-Pérez
Material and Methods: Dual energy CT was performed using a Discovery CT750 HD scanner (GE Healthcare, USA). The DECTs were performed using fast kV-switching gemstone spectral imaging (GSI) between 80 kV and 140 kV. The CT data were reconstructed both with and without MAR to the monochromatic energies of 60 keV, 90 keV and 120 keV. CIRS phantom model 062 (CIRS Inc., USA) was used to calibrate HU to electron density in that set of monochromatic energies. Two additional sets of CT were performed after including a home-made steel insert both on the periphery and in the center of the phantom, and different images were compared in the presence of artefacts.
Results: Different calibrations for monochromatic energies showed good HU to electron density linear correlation in all cases (R² ranging from 0.91 to 0.998). Linearity was better for higher virtual monochromatic energies. The slope maximum change in HU to electron density curves was 24.4% when comparing polienergetic "standard" CT with 120 keV virtual image. For monochromatic energy curve calibrations, differences are up to 38.0% between 60 and 120 keV monochromatic energy. No significant differences were found in calibrations between using MAR or not. The maximum slope change in HU to electron density curves was 2.4% for 120 keV monochromatic images after MAR reconstruction. The maximum change of the HU of an insert after the inclusion of artefacts was of 34,0 HU for 120 keV monochromatic energy compared to 50.7 HU for a conventional CT (Figure 1 ). 
Conclusion:
The reduction of metal-related artefacts is improved at high monochromatic energies due to both the decrease of beam hardening effect and the use of MAR algortihm. Therefore, using high keV monochromatic DECT virtual images and MAR algorithm is technically viable in radiotherapy planning since HU to electron density calibrations are feasible with monochromatic DECT image. DICOM standard is used for monochromatic virtual images and they were successfully exported to XiO treatment planning system (Elekta, Crawley, UK).
EP-1837
Impact on patient positioning using four CT datasets for image registration with CBCTs in lung SBRT M. Oechsner
